Latest News for: brca2
Edit
Indian Institute of Technology Madras study reveals need for broader breast cancer testing in India as commonly tested BRCA1 and BRCA2 genes account for less than 8% of cases
The Times of India 02 Mar 2026
One in four Indian breast cancer patients carries inherited genetic variants that raise cancer risk beyond the commonly tested BRCA1 and BRCA2 genes — which can boost lifetime risk up to 70% — found a study by Indian Institute of Technology Madras.
Edit
Brattleboro Reformer
13 Dec 2025
U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer ...
Brattleboro Reformer
13 Dec 2025
Edit
U.S. FDA approves AKEEGA® as the first precision therapy for BRCA2-mutated metastatic castration-sensitive prostate cancer with 54% reduction in disease progression vs standard of care*
PR Newswire 13 Dec 2025
Expanded indication for AKEEGA® (niraparib and abiraterone acetate dual-action tablet) plus prednisone marks the first FDA-approved precision medicine combination treatment for patients with BRCA2-mutated mCSPC.
- 1